Unknown PHASE4 INTERVENTIONAL 1-arm NCT03260010

Efficacy and Safety of Intravenous Fosfomycin in Prosthetic Joint Infection (PROOF)

Efficacy and Safety of Intravenous Fosfomycin in Prosthetic Joint Infection (PJI) Caused by Staphylococci, Streptococci, Enterococci and Gram-negative Bacilli, Including Mixed Infections and Culture Negative PJI's (PROOF-Study)

Sponsor: Charite University, Berlin, Germany

Conditions Prosthetic Joint Infection

Interventions Fosfomycin

Updated 8 times since 2017 Last updated: Apr 17, 2018 Started: Jan 15, 2018 Primary completion: Apr 15, 2020 Completion: Apr 15, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Prosthetic Joint Infection and is currently ongoing. Charite University, Berlin, Germany leads this study, which shows 8 recorded versions since 2018 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Recruiting PHASE4
Jun 2018 — Jan 2021 [monthly]

Recruiting PHASE4

▶ Show 3 earlier versions

May 2018 — Jun 2018 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Oct 2017 — May 2018 [monthly]

Not Yet Recruiting PHASE4
Sep 2017 — Oct 2017 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Charite University, Berlin, Germany
Pro-Implant Foundation

Data source: Pro-Implant Foundation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Berlin, Germany